In a report released yesterday, Mara Goldstein from Mizuho Securities assigned a Buy rating to Fate Therapeutics (FATE), with a price target of ...
The post Fate Therapeutics (FATE) Gets a Buy Rating from Mizuho Securities appeared first on Smarter Analyst.
In a report released yesterday, Mara ...

https://www.smarteranalyst.com/new-blurbs/fate-therapeutics-fate-gets-a-buy-rating-from-mizuho-securities-3/

#SmarterAnalyst